Dysplastic features in 408 patients with AML
Dysplastic lineages/parameter . | No. of cases (%) . | No. of cases . | MLD . | No. of cases (%) . | P for EFS . | P for OS . |
---|---|---|---|---|---|---|
No dysplasia | 132 (32.3) | No | 261 (64.0)* | .333 | .202 | |
One dysplastic cell lineage | 129 (31.9) | No | ||||
DysG | 34 | |||||
DysE | 12 | |||||
Dys M | 83 | |||||
Two dysplastic cell lineages | 111 (30.0) | Yes | ||||
DysG + DysE | 12 | 147 (36.0)† | ||||
DysG + DysM | 79 | |||||
DysE + DysM | 20 | |||||
Trilineage dysplasia | 36 (8.8) | Yes | ||||
Total | 408 (100) | 408 (100) |
Dysplastic lineages/parameter . | No. of cases (%) . | No. of cases . | MLD . | No. of cases (%) . | P for EFS . | P for OS . |
---|---|---|---|---|---|---|
No dysplasia | 132 (32.3) | No | 261 (64.0)* | .333 | .202 | |
One dysplastic cell lineage | 129 (31.9) | No | ||||
DysG | 34 | |||||
DysE | 12 | |||||
Dys M | 83 | |||||
Two dysplastic cell lineages | 111 (30.0) | Yes | ||||
DysG + DysE | 12 | 147 (36.0)† | ||||
DysG + DysM | 79 | |||||
DysE + DysM | 20 | |||||
Trilineage dysplasia | 36 (8.8) | Yes | ||||
Total | 408 (100) | 408 (100) |